Table 2.
Diagnostic criteria used to assess JE laboratory-confirmed patients.*
| Level 1 | JEV RNA detected in any specimen by RT-PCR. |
| Virus isolation by inoculation of any specimen in cell culture or animal with characteristic cytopathic effect and confirmation by detection of JEV RNA or virus antigen. | |
| JEV virus antigen detected from brain tissue or CSF by immunofluorescence or immunohistochemistry | |
| Level 2 | Seroconversion or ≥ 4x rise in anti-JEV Ab by seroneutralization or detection of neutralizing antibody in CSF; Samples should be tested alongside other endemic flaviviruses (e.g., dengue viruses) |
| Level 3 | Anti-JEV IgM detected in CSF; Samples should be tested alongside other endemic flaviviruses (e.g., dengue viruses) |
| Seroconversion or 4x rise in anti-JEV Ab HI, CF, IFA, or seroconversion by ELISA; Samples should be tested alongside other endemic flaviviruses (e.g., dengue viruses). | |
| Level 4 | Anti-JEV IgM detected in serum in one sample (acute/convalescent), or seroneutralisation tested in one sample or single high titer HI/CF/IFA; Samples must be tested alongside other endemic flaviviruses (e.g., dengue viruses) |
RT-PCR = reverse transcription-polymerase chain reaction; RNA = ribonucleic acid; CSF = cerebrospinal fluid; Ab = antibody; ELISA = enzyme-linked immunosorbent assay; HI = haemagglutination inhibition; CF = complement fixation test; IFA = indirect immunofluorescence assay.
Confirmation of JE is categorized into levels 1-4 based on existing WHO and CDC criteria, such that level 1 provides the highest level of confidence.